Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Microsoft
MSFT
|
$511M |
| 2 |
Lowe's Companies
LOW
|
$397M |
| 3 |
Amazon
AMZN
|
$329M |
| 4 |
Match Group
MTCH
|
$276M |
| 5 |
Goldman Sachs
GS
|
$276M |
Top Sells
| 1 |
FirstEnergy
FE
|
$742M |
| 2 |
Fiserv
FI
|
$467M |
| 3 |
Qiagen
QGEN
|
$391M |
| 4 |
Fidelity National Information Services
FIS
|
$378M |
| 5 |
Accenture
ACN
|
$370M |
Sector Composition
| 1 | Technology | 22.46% |
| 2 | Financials | 16.55% |
| 3 | Healthcare | 16.09% |
| 4 | Industrials | 13.18% |
| 5 | Communication Services | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Fastenal
FAST
$57.7B
| $706K | ﹤0.01% |
31,336
+6,972
| +29% | +$157K |
|
802
Enanta Pharmaceuticals
ENTA
$190M
| $705K | ﹤0.01% |
15,407
-22,703
| -60% | -$1.04M |
|
803
Co-Diagnostics
CODX
$11.9M
| $695K | ﹤0.01% |
+51,133
| New | +$695K |
|
804
TD Synnex
SNX
$12.3B
| $694K | ﹤0.01% |
+9,908
| New | +$694K |
|
805
Graco
GGG
$14.3B
| $679K | ﹤0.01% |
11,075
+2,464
| +29% | +$151K |
|
|
CNSL
806
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $676K | ﹤0.01% |
+118,743
| New | +$676K |
|
|
GNMK
807
DELISTED
GenMark Diagnostics, Inc
GNMK
| $666K | ﹤0.01% |
+46,916
| New | +$666K |
|
|
GTHX
808
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $641K | ﹤0.01% |
+55,458
| New | +$641K |
|
|
RDUS
809
DELISTED
Radius Health, Inc.
RDUS
| $632K | ﹤0.01% |
55,771
-2,186
| -4% | -$24.8K |
|
810
Open Text
OTEX
$8.51B
| $617K | ﹤0.01% |
14,613
-331
| -2% | -$14K |
|
811
Phathom Pharmaceuticals
PHAT
$851M
| $614K | ﹤0.01% |
16,755
-657
| -4% | -$24.1K |
|
812
Acco Brands
ACCO
$363M
| $601K | ﹤0.01% |
103,625
-4,061
| -4% | -$23.6K |
|
813
Heritage Insurance Holdings
HRTG
$759M
| $594K | ﹤0.01% |
58,649
-2,299
| -4% | -$23.3K |
|
814
RELX
RELX
$85.5B
| $594K | ﹤0.01% |
26,555
-66,772
| -72% | -$1.49M |
|
815
Martin Marietta Materials
MLM
$37.3B
| $588K | ﹤0.01% |
+2,499
| New | +$588K |
|
816
Arcturus Therapeutics
ARCT
$455M
| $582K | ﹤0.01% |
+13,563
| New | +$582K |
|
|
OCFT
817
OneConnect Financial Technology
OCFT
$277M
| $582K | ﹤0.01% |
2,730
-46,861
| -94% | -$9.99M |
|
818
Varex Imaging
VREX
$484M
| $580K | ﹤0.01% |
45,596
-32,236
| -41% | -$410K |
|
|
CALA
819
DELISTED
Calithera Biosciences, Inc
CALA
| $574K | ﹤0.01% |
+8,313
| New | +$574K |
|
820
AnaptysBio
ANAB
$590M
| $572K | ﹤0.01% |
+38,784
| New | +$572K |
|
821
Akebia Therapeutics
AKBA
$801M
| $569K | ﹤0.01% |
226,786
-8,886
| -4% | -$22.3K |
|
|
CBD
822
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $551K | ﹤0.01% |
44,621
+4,169
| +10% | +$51.5K |
|
|
TBIO
823
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $526K | ﹤0.01% |
+38,647
| New | +$526K |
|
824
Levi Strauss
LEVI
$8.92B
| $525K | ﹤0.01% |
39,199
-858,338
| -96% | -$11.5M |
|
825
Bruker
BRKR
$4.52B
| $517K | ﹤0.01% |
12,995
+2,890
| +29% | +$115K |
|